A carregar...
PD-1/PD-L1 axis in lung cancer
Cancer immunotherapies have revolutionized the treatment of non-small cell lung cancer. Yet, only a small subset of patients will benefit from PD-(L)1 blockade. PD-L1 tumor cell expression is the only approved biomarker at present. Tumor mutational burden and other emerging biomarkers should improve...
Na minha lista:
| Publicado no: | Cancer J |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5784856/ https://ncbi.nlm.nih.gov/pubmed/29360723 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/PPO.0000000000000300 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|